Characterization of melanoma cells capable of propagating tumors from a single cell

Cancer Research

Volumn 70, Issue 1, 2010, Pages 388-397

  Held, Matthew A ^a   Curley, David P ^a   Dankort, David ^b   McMahon, Martin ^c   Muthusamy, Viswanathan ^d   Bosenberg, Marcus W ^a,d  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; CD133 ANTIGEN; CD20 ANTIGEN; CD34 ANTIGEN; CISPLATIN; EPITHELIAL CELL ADHESION MOLECULE; HERMES ANTIGEN; PROTEIN P75; STAGE SPECIFIC EMBRYO ANTIGEN 1; STEM CELL FACTOR RECEPTOR; TEMOZOLOMIDE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CARCINOGENESIS; IN VITRO STUDY; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD34; BETA CATENIN; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENES, P16; MELANOMA, EXPERIMENTAL; MICE; NEOPLASTIC STEM CELLS; PHENOTYPE; PROTO-ONCOGENE PROTEINS B-RAF; PTEN PHOSPHOHYDROLASE;

EID: 75149165632     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-2153     Document Type: Article

References (35)

1. Clarke MF, Dicks JE, Dirks PB, et al. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006;66:9339-44.
2. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumors: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8:755-68.
3. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994;367:645-8.
4. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63:5821-8.
5. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003;100:3983-8.
6. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 2007;445:106-10.
7. Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res 2007;67:1030-7.
8. Schatton T, Murphy GF, Frank NY, et al. Identification of cells initiating human melanomas. Nature 2008;451:345-9.
9. + cancer stem cells in human liver cancer. Cancer Cell 2008;13:153-66.
10. Zhang S, Balch C, Chan MW, et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 2008;68:4311-20.
11. Vermeulen L, Todaro M, de Sousa Mello F, et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A 2008;105:13427-32.
12. + cell population is enriched in tumor-initiating cells. Cancer Res 2007;67:6796-805.
13. Hope KJ, Jin L, Dick JE. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 2004;7:738-43.
14. Pretlow TG, Delmoro CM, Dilley GG, Spadafora CG, Pretlow TP. Transplantation of human prostatic carcinoma into nude mice in Matrigel. Cancer Res 1991;14:3814-7.
15. Kelly P, Dakic A, Adams J, Nutt S, Strasser A. Tumor growth need not be driven by rare cancer stem cells. Science 2007; 318:1722.
16. Dick JE. Looking ahead in cancer stem cell research. Nat Biotechnol 2009;27:44-6.
17. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumor formation by single human melanoma cells. Nature 2008;456:593-8.
18. Inoue-Narita T, Hamada K, Sasaki T, et al. Pten deficiency in melanocytes results in hair graying and susceptibility to carcinogeninduced melanomagenesis. Cancer Res 2008;68:5760-8.
19. Wong CE, Paratore C, Dours-Zimmermann MT, et al. Neural crestderived cells with stem cell features can be traced back to multiple lineages in the adult skin. J Cell Biol 2006;175:1005-15.
20. Chin L, Garraway LA, Fisher DE. Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev 2006;16:2149-82.
21. You MJ, Castrillon DH, Bastian BC, et al. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. Proc Natl Acad Sci U S A 2002;99:1455-60.
22. Harada N, Tamai Y, Ishikawa T, et al. Intestinal polyposis in mice with a dominant stable mutation of the β-catenin gene. EMBO J 1999;18: 5931-42.
23. Dankort D, Curley DP, Cartlidge RA, et al. BRafV600E cooperates with Pten silencing to induce metastatic melanoma. Nat Genet 2009;41:544-52.
24. Bosenberg M, Muthusamy V, Curley DP, et al. Characterization of melanocyte-specific inducible Cre recombinase transgenic mice. Genesis 2006;44:262-7.
25. Delmas V, Beermann F, Martinozzi S, et al. β-Catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev 2007;21:2923-35.
26. Kameyama K, Takemura T, Hamada Y, et al. Pigment production in murine melanoma cells is regulated by tyrosinase, tyrosinaserelated protein 1 (TRP1), DOPAchrome tautomerase (TRP2), and a melanogenic inhibitor. J Invest Dermatol 1993;100:126-31.
27. Bolander A, Agnarsdóttir M, Wagenius G, et al. Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma. Melanoma Res 2008;18:412-9.
28. Dankort D, Filenova E, Collado M, Serrano M, Jones K, McMahon M. A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Genes Dev 2007;21: 379-84.
29. Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, Visvader JE. The mammary progenitor marker CD61/β3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res 2008;68:7711-7.
30. Tamase A, Muraguchi T, Naka K, et al. Identification of tumorinitiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin. Proc Natl Acad Sci U S A 2009;106:17163-8.
31. Marumoto T, Tashiro A, Friedmann-Morvinski D, et al. Development of a novel mouse glioma model using lentiviral vectors. Nat Med 2009; 15:110-6.
32. Reya T, Morrison S, Clarke M, Weissman I. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-11.
33. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756-60.
34. Shafee N, Smith CR, Wei S, et al. Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors. Cancer Res 2008;68:3243-50.
35. Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One 2008;8:e3077.